Daiwa Securities Group Inc. lifted its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 24.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,314 shares of the life sciences company’s stock after acquiring an additional 1,054 shares during the period. Daiwa Securities Group Inc.’s holdings in Illumina were worth $1,059,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Paradigm Asset Management Co. LLC lifted its position in Illumina by 5.6% during the second quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after buying an additional 50 shares during the period. Patriot Financial Group Insurance Agency LLC lifted its position in Illumina by 1.4% during the second quarter. Patriot Financial Group Insurance Agency LLC now owns 3,126 shares of the life sciences company’s stock worth $528,000 after buying an additional 43 shares during the period. Cambridge Investment Research Advisors Inc. lifted its position in Illumina by 298.7% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 10,447 shares of the life sciences company’s stock worth $1,813,000 after buying an additional 7,827 shares during the period. Eagle Asset Management Inc. purchased a new position in Illumina during the second quarter worth about $27,175,000. Finally, Stephens Investment Management Group LLC lifted its position in Illumina by 0.5% during the second quarter. Stephens Investment Management Group LLC now owns 168,706 shares of the life sciences company’s stock worth $29,274,000 after buying an additional 803 shares during the period. Hedge funds and other institutional investors own 92.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Daiwa Securities Group Inc. Has $1.06 Million Position in Illumina, Inc. (ILMN)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.watchlistnews.com/daiwa-securities-group-inc-has-1-06-million-position-in-illumina-inc-ilmn/1699826.html.

Shares of Illumina, Inc. (NASDAQ:ILMN) opened at $208.94 on Monday. Illumina, Inc. has a 12 month low of $119.37 and a 12 month high of $214.50. The company has a current ratio of 4.22, a quick ratio of 3.73 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $30,505.24, a P/E ratio of 61.09, a price-to-earnings-growth ratio of 3.45 and a beta of 0.74.

Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.12. Illumina had a return on equity of 19.42% and a net margin of 30.34%. The firm had revenue of $714.00 million during the quarter, compared to analyst estimates of $692.77 million. During the same quarter last year, the firm earned $0.97 EPS. Illumina’s quarterly revenue was up 17.6% on a year-over-year basis. equities research analysts forecast that Illumina, Inc. will post 3.75 earnings per share for the current year.

In other news, SVP Charles Dadswell sold 145 shares of Illumina stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $205.71, for a total value of $29,827.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mostafa Ronaghi sold 20,000 shares of Illumina stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $210.00, for a total value of $4,200,000.00. Following the completion of the transaction, the senior vice president now owns 86,725 shares of the company’s stock, valued at approximately $18,212,250. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 187,964 shares of company stock valued at $38,454,069. 1.60% of the stock is owned by insiders.

Several equities analysts recently weighed in on the company. Argus increased their target price on Illumina from $205.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, September 13th. Leerink Swann reiterated an “outperform” rating and set a $225.00 target price (up from $207.00) on shares of Illumina in a research report on Tuesday, September 12th. Wells Fargo & Company reiterated a “market perform” rating and set a $205.00 target price (up from $200.00) on shares of Illumina in a research report on Wednesday, October 25th. Robert W. Baird upgraded Illumina from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $184.00 to $228.00 in a research report on Wednesday, October 25th. Finally, Bank of America Corporation increased their target price on Illumina from $215.00 to $240.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. Illumina currently has an average rating of “Hold” and a consensus price target of $200.88.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.